Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment-Reference-Cited by-同舟云学术

Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment

Published:2018-12 Issue: Volume:11 Page:62-74
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Denton Nicholas L.,Chen Chun-Yu,Hutzen Brian,Currier Mark A.,Scott Thomas,Nartker Brooke,Leddon Jennifer L.,Wang Pin-Yi,Srinivas Rachelle,Cassady Kevin A.,Goins William F.,Cripe Timothy P.

Funder

National Cancer Institute

Cancer Free Kids Pediatric Cancer Research Alliance

Research Institute at Nationwide Children's Hospital

NIH HHS

The Ohio State University

Nationwide Children's Hospital

Alex’s Lemonade Stand

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference50 articles.

1. Macrophage infiltration predicts a poor prognosis for human Ewing sarcoma;Fujiwara;Am. J. Pathol.,2011

2. The Ewing’s sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1;May;Mol. Cell. Biol.,1993

3. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting;Theisen;Oncotarget,2016

4. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation;May;Proc. Natl. Acad. Sci. USA,1993

5. Tumor-associated macrophages in oncolytic virotherapy: friend or foe?;Denton;Biomedicines,2016

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy;Clinical and Experimental Medicine;2024-08-28

2. Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors;Frontiers in Immunology;2024-06-25

3. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies;Frontiers in Cell and Developmental Biology;2024-06-10

4. Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma;2024-03-03

5. Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages;Journal of Translational Medicine;2023-11-22